CD&R and McKesson agree to acquire Option Care Health
+1 new source since this summary was written
On October 6, 2026, Clayton, Dubilier & Rice and McKesson agreed to acquire Option Care Health for $32.05 per share, implying approximately $5.8 billion in enterprise value. CD&R will take approximately 51% ownership, while McKesson will invest approximately $1.4 billion for approximately 49%. Completion is targeted for the first half of calendar year 2027, conditional on stockholder approval and required regulatory clearances.
Why it matters
Option Care Health shareholders would receive a defined cash exit if the transaction closes, and the company would leave Nasdaq and become privately held. McKesson would gain minority exposure to Option Care Health's home and alternate-site infusion business, while Finimize's note says the deal should have minimal effect on McKesson's earnings and risk profile.
Key facts
- 1The transaction values Option Care Health at approximately $5.8 billion in enterprise value. gurufocus.com
- 2CD&R will hold approximately 51% of Option Care Health after completion. gurufocus.com
- 3McKesson will invest approximately $1.4 billion for approximately 49% ownership. gurufocus.com
- 4The offer price represents a premium of approximately 37% to Option Care Health's October 5, 2026 closing price. gurufocus.com
- 5Option Care Health's common stock will no longer be publicly listed on Nasdaq after the transaction closes. gurufocus.com
Open questions
- One report gives a 2024 closing expectation, conflicting with the announced first half of calendar year 2027 timetable.
Summary written by AlphAI AI Desk from 20 of 24 sources. Not investment advice. Figures are as stated by the linked sources.